Why the study?
Do insulin-sensitizing agents cause cytotoxic damage by eliminating defenses against fuel overload in the heart?
Do insulin-sensitizing agents cause cytotoxic damage by eliminating defenses against fuel overload in the heart?
This review proposes that myocardial insulin resistance is a protective mechanism against fuel overload, challenging the use of insulin sensitizers in heart failure.
May warrant caution with insulin sensitizers in HF; leaves open whether myocardial insulin resistance protects against fuel overload.
Reversing impaired insulin sensitivity has been suggested as treatment for heart failure. However, recent clinical evidence suggests the opposite. Here we present a line of reasoning in support of the hypothesis that insulin resistance protects the heart from the consequences of fuel overload in the dysregulated metabolic state of obesity and diabetes. We discuss pathways of myocardial fuel toxicity, as well as several layers of defense against fuel overload. Our reassessment of the literature suggests that in the heart, insulin-sensitizing agents result in an elimination of some of the defenses, leading to cytotoxic damage. In contrast, a normalization of fuel supply should either prevent or reverse the process. Taken together, we offer a new perspective on insulin resistance of the heart.
No takes yet. Share an insight, caveat, or question.
Taegtmeyer et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: